Health inequalities modular update to NICE health technology evaluations: the manual (PMG36) Methods / process manual consultation NICE process and methods 31 January 2025 Highly specialised ...

5.3. Presentation by the lead team - Part 2 only ( closed session) 5.4. Agreement on the content of the Draft Guidance (DG) or Final Draft Guidance (FDG) - Part 2 only (closed session) Belantamab ...

A list of downloadable documents created during development.

The Department of Health has asked NICE to produce guidance on using the above technology in the NHS in England. The company has informed NICE that it will not provide an evidence submission for this ...

The Department of Health has asked NICE to produce guidance on using the above technology in the NHS in England. The company has informed NICE that it will not provide an evidence submission for this ...

A list of downloadable documents created during development.

A list of downloadable documents created during development.

Reason for decision Anticipate the topic will be of importance to patients, carers, professionals, commissioners and the health of the public to ensure clinical benefit is realised, inequalities in ...

Adults may need support to manage their medicines safely and effectively, and for some people this will be provided as part of a home care service. When medicines support starts, tell the person’s GP ...

Suggested remit: To appraise the clinical and cost effectiveness of Semaglutide within its marketing authorisation for treating cardiovascular disease.

If you’re commenting for an organisation, your organisation needs to be registered as a stakeholder. We can accept comments from individuals. These will be considered, but you won’t get a formal ...